TRAW
Price:
$1.28
Market Cap:
$11.70M
Traws Pharma, Inc., a biopharmaceutical firm in the clinical development stage, is dedicated to creating novel small-molecule medications delivered orally to combat both respiratory viral infections and various forms of cancer. Its pipeline includes experimental treatments specifically designed to overcome drug resistance in influenza and COVID-19. These promising candidates include TRX01 (travatrelvir), an Mpro/3CL inhibitor currently undergoing development for COVID-19, and TRX100 (viroxavir), an endonuclease inhibitor advancing through trials for pandemic influenza. Additionally, Traws Pharma's oncology portfolio features narazaciclib, a multi-kinase CDK4/6 inhibitor. This compound is pre...[Read more]
Industry
Biotechnology
IPO Date
2013-07-25
Stock Exchange
NASDAQ
Ticker
TRAW
According to Traws Pharma, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 0.43. This represents a change of -68.22% compared to the average of 1.35 of the last 4 quarters.
The mean historical Current Ratio of Traws Pharma, Inc. over the last ten years is 2.90. The current 0.43 Current Ratio has changed 1.38% with respect to the historical average. Over the past ten years (40 quarters), TRAW's Current Ratio was at its highest in in the December 2013 quarter at 10.10. The Current Ratio was at its lowest in in the June 2012 quarter at 0.
Average
2.90
Median
2.22
Minimum
0.49
Maximum
9.06
Discovering the peaks and valleys of Traws Pharma, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 359.14%
Maximum Annual Current Ratio = 9.06
Minimum Annual Increase = -78.35%
Minimum Annual Current Ratio = 0.49
| Year | Current Ratio | Change |
|---|---|---|
| 2025 | 0.72 | -66.91% |
| 2024 | 2.16 | -11.97% |
| 2023 | 2.46 | -49.74% |
| 2022 | 4.89 | -46.05% |
| 2021 | 9.06 | 359.14% |
| 2020 | 1.97 | -30.26% |
| 2019 | 2.83 | 34.46% |
| 2018 | 2.11 | 328.37% |
| 2017 | 0.49 | -78.35% |
| 2016 | 2.27 | -25.52% |
The current Current Ratio of Traws Pharma, Inc. (TRAW) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
1.78
5-year avg
3.86
10-year avg
2.90
Traws Pharma, Inc.’s Current Ratio is less than Cingulate Inc. (2.55), less than Dogwood Therapeutics, Inc. (5.86), less than Imunon, Inc. (1.59), less than Cocrystal Pharma, Inc. (2.66), less than Sensei Biotherapeutics, Inc. (14.39), less than Bolt Biotherapeutics, Inc. (3.51), less than Mustang Bio, Inc. (2.10), less than Evogene Ltd. (2.79), less than BioRestorative Therapies, Inc. (2.35), less than Immuron Limited (8.04),
| Company | Current Ratio | Market cap |
|---|---|---|
| 2.55 | $27.36M | |
| 5.86 | $2.94M | |
| 1.59 | $5.09M | |
| 2.66 | $10.20M | |
| 14.39 | $17.45M | |
| 3.51 | $8.76M | |
| 2.10 | $5.61M | |
| 2.79 | $5.03M | |
| 2.35 | $3.17M | |
| 8.04 | $7.67M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Traws Pharma, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Traws Pharma, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is Traws Pharma, Inc.'s Current Ratio?
How is the Current Ratio calculated for Traws Pharma, Inc. (TRAW)?
What is the highest Current Ratio for Traws Pharma, Inc. (TRAW)?
What is the 3-year average Current Ratio for Traws Pharma, Inc. (TRAW)?
What is the 5-year average Current Ratio for Traws Pharma, Inc. (TRAW)?
How does the current Current Ratio for Traws Pharma, Inc. (TRAW) compare to its historical average?